Black Bird Biotech, Inc.: 10-Q filed 2011-08-15

Name: Black Bird Biotech, Inc.: 10-Q filed 2011-08-15
Creator: Black Bird Biotech, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Black Bird Biotech, Inc. reported in its quarterly report filed 2011-08-15 (fiscal Q2 2011): 17 published measures, 48 facts as tagged in accession 0001354488-11-002751.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-08-15
Fiscal period: fiscal Q2 2011
Accession: 0001354488-11-002751 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Black Bird Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-06-30	90,148	USD
At 2010-12-31	503,804	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-06-30	325,036	USD
At 2010-12-31	636,586	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2011-06-30	-234,888	USD
At 2010-12-31	-132,782	USD
At 2009-12-31	26,561	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-43,377	USD	91
2011-01-01 to 2011-06-30	-102,106	USD	181
2010-01-01 to 2010-12-31	-8,272,310	USD	365
2010-04-01 to 2010-06-30	-37,124	USD	91
2010-01-01 to 2010-06-30	-141,277	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	158,458	USD	181
2010-01-01 to 2010-06-30	-138,195	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-331,666	USD	181
2010-01-01 to 2010-06-30	598,020	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	5,000	USD	181
2010-01-01 to 2010-06-30	-7,930,492	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-39,668	USD	91
2011-01-01 to 2011-06-30	-93,836	USD	181
2010-04-01 to 2010-06-30	-34,253	USD	91
2010-01-01 to 2010-06-30	-138,406	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	45,148	USD
At 2010-12-31	498,804	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	3,709	USD	91
2011-01-01 to 2011-06-30	8,270	USD	181
2010-04-01 to 2010-06-30	2,871	USD	91
2010-01-01 to 2010-06-30	2,871	USD	181

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-06-30	25,036	USD
At 2010-12-31	16,920	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2011-06-30	0	USD
At 2010-12-31	5,000	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	5,102	USD	91
2011-01-01 to 2011-06-30	67,892	USD	181
2010-04-01 to 2010-06-30	-1,895	USD	91
2010-01-01 to 2010-06-30	-11,842	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	86,402,665	shares
At 2010-12-31	86,402,665	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-06-30	8,281,164	USD
At 2010-12-31	8,281,164	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	44,770	USD	91
2011-01-01 to 2011-06-30	161,728	USD	181
2010-04-01 to 2010-06-30	32,358	USD	91
2010-01-01 to 2010-06-30	126,564	USD	181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-3,709	USD	91
2011-01-01 to 2011-06-30	-8,270	USD	181
2010-04-01 to 2010-06-30	-2,871	USD	91
2010-01-01 to 2010-06-30	-2,871	USD	181

Inspect the source

Entity: Black Bird Biotech, Inc. / CIK 0001409999
Captured: 2026-09-22 19:47 UTC
SEC response SHA-256: df936db10ff162447a769152b36bd1ddff9f21ac96d53dd4e87253b660581055

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001409999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))